Disclosure Of Fair Value Measurement [Text Block]

GenSight Biologics S.A. - Filing #2816652

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
56,648,000 EUR
47,361,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
15,989,000 EUR
137,726,000 EUR
181,175,000 EUR
1,158,000 EUR
28,617,000 EUR
11,749,000 EUR
108,034,000 EUR
1,022,000 EUR
152,776,000 EUR
34,015,000 EUR
108,034,000 EUR
30,868,000 EUR
10,518,000 EUR
87,565,000 EUR
128,130,000 EUR
821,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.